About the event

Held over a weekend, the event is structured around a series of exhibitions, workshops, and panel discussions. The exhibitions showcase a curated selection of photographs that tell compelling stories from various corners of the globe, each image accompanied by detailed narratives that provide context and deeper insight into the historical significance of the scenes depicted. These photographs are drawn from the archives of renowned photographers, as well as emerging talents, ensuring a blend of both classical and contemporary perspectives.

Cliff Palace, Colorado
Market Momentum: DBV Technologies ADR (DBVT) Registers a -0.42% Decrease, Closing at $12.9 – DwinneX

Market Momentum: DBV Technologies ADR (DBVT) Registers a -0.42% Decrease, Closing at $12.9

Kevin Freeman

Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.

DBV Technologies ADR (NASDAQ: DBVT) closed the day trading at $12.9 down -0.42% from the previous closing price of $12.96. In other words, the price has decreased by -$0.42 from its previous closing price. On the day, 0.24 million shares were traded. DBVT stock price reached its highest trading level at $13.33 during the session, while it also had its lowest trading level at $12.82.

Ratios:

For a better understanding of DBVT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.80 and its Current Ratio is at 1.80. In the meantime, Its Debt-to-Equity ratio is 0.30 whereas as Long-Term Debt/Eq ratio is at 0.13.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 20 ’25 when Mohideen Pharis sold 6,496 shares for $2.88 per share. The transaction valued at 18,708 led to the insider holds 103,153 shares of the business.

Mohideen Pharis sold 1,624 shares of DBVT for $4,498 on Nov 21 ’25. The Chief Medical Officer now owns 101,529 shares after completing the transaction at $2.77 per share. On Jul 29 ’25, another insider, Mohideen Pharis, who serves as the Chief Medical Officer of the company, sold 464 shares for $2.22 each. As a result, the insider received 1,030 and left with 109,649 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DBVT now has a Market Capitalization of 520907008 and an Enterprise Value of 2118204928. Its current Enterprise Value per Revenue stands at 384.988.

Stock Price History:

The Beta on a monthly basis for DBVT is -1.08, which has changed by 2.323077 over the last 52 weeks, in comparison to a change of 0.12159383 over the same period for the S&P500. Over the past 52 weeks, DBVT has reached a high of $18.00, while it has fallen to a 52-week low of $2.70. The 50-Day Moving Average of the stock is -4.45%, while the 200-Day Moving Average is calculated to be 35.01%.

Shares Statistics:

Over the past 3-months, DBVT traded about 111.49K shares per day on average, while over the past 10 days, DBVT traded about 124540 shares per day. A total of 38.87M shares are outstanding, with a floating share count of 29.74M. Insiders hold about 23.49% of the company’s shares, while institutions hold 34.91% stake in the company. Shares short for DBVT as of 1763078400 were 32706 with a Short Ratio of 0.29, compared to 1760486400 on 21598. Therefore, it implies a Short% of Shares Outstanding of 32706 and a Short% of Float of 0.11.

Earnings Estimates

. The current rating of DBV Technologies ADR (DBVT) is the result of assessments by 2.0 analysts actively engaged in evaluating its market dynamics.The consensus estimate for the next quarter is -$0.38, with high estimates of -$0.38 and low estimates of -$0.38.

Analysts are recommending an EPS of between -$0.93 and -$0.94 for the fiscal current year, implying an average EPS of -$0.93. EPS for the following year is -$0.88, with 3.0 analysts recommending between -$0.28 and -$1.44.

Revenue Estimates

2 analysts predict $1.52M in revenue for. The current quarter. It ranges from a high estimate of $2.5M to a low estimate of $533k. As of. The current estimate, DBV Technologies ADR’s year-ago sales were $517.72kFor the next quarter, 2 analysts are estimating revenue of $762k. There is a high estimate of $1.1M for the next quarter, whereas the lowest estimate is $425k.

A total of 2 analysts have provided revenue estimates for DBVT’s current fiscal year. The highest revenue estimate was $6.78M, while the lowest revenue estimate was $4.88M, resulting in an average revenue estimate of $5.83M. In the same quarter a year ago, actual revenue was $3.88MBased on 3 analysts’ estimates, the company’s revenue will be $4.52M in the next fiscal year. The high estimate is $7.46M and the low estimate is $1.7M.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.